TXNM Energy Stock Hits Records as One Fund Builds an $8 Million Position

Hong Kong-based Athos Capital initiated a new 13F position in TXNM Energy, acquiring 142,842 shares valued at $8.08 million (≈5.06% of its $159.62M reportable U.S. equity AUM) as of Sept. 30. TXNM trades around $58.92 (market cap $6.42B) with TTM revenue of $2.11B and net income of $176.92M; Q3 GAAP EPS was $1.22 (ongoing $1.33), supported by approved rate increases and transmission recovery, and the company is investing in grid infrastructure and a $78M battery project. The stock’s upside is effectively capped by a pending Blackstone Infrastructure acquisition at $61.25/share, while regulatory approval timelines (potentially into late 2026) remain the primary risk — a setup that makes a concentrated fund comfortable allocating a mid-single-digit weight.

Analysis

Market structure: The Athos stake and the pending Blackstone $61.25 take-private cap reframe TXNM as a merger-arb/security with limited upside (~$2.33 or ~3.8% from $58.92) and regulatory-driven timing. Direct beneficiaries are current TXNM holders and private-infra bidders (Blackstone); losers are arbitrageurs who face thin spreads if regulatory approval drags into late-2026. Broader utility M&A comps may rerate, lifting regional peers on takeover expectations while compressing free-float liquidity for TXNM.

Risk assessment: Key tail risks are regulatory rejection/conditions (NM PRC or TX PUC) or a competing bidder withdrawing — either could drop shares 15–30% (to ~$40–50). Immediate risk (days): spread volatility around filings; short-term (weeks–months): rate-case decisions and regulatory submissions; long-term (quarters): execution of grid investments and potential leverage changes under Blackstone. Hidden dependencies include debt covenants and any divestiture demands from regulators.

Trade implications: Pure arb is low-yield vs duration: buying TXNM at ≤$59 with a 12–18 month horizon yields ~4–8% if closed; hedge with puts or sell covered calls to improve IRR. Relative-value: long TXNM arb vs short broad-utility ETF (e.g., XLU) isolates deal-specific risk. Options: buy 12-month $55 puts as tail insurance or sell Jan-2026 $62.50 covered calls to capture premium.

Contrarian angles: Consensus underestimates upside from higher-than-expected regulatory concessions or competing bids that could lift price >$65; conversely, the market may be underpricing a slow approval timeline — current ~3.8% spread is likely inadequate for 12–18 month regulatory risk. Historical utility takeovers show both surprise top-up bids and protracted approvals; position sizing should reflect this binary outcome.

Key Decisions for Investors

• Establish a merger-arbitrage long in TXNM (NYSE:TXNM) at ≤$59, position size 1–2% of portfolio AUM, horizon 12–18 months; simultaneously buy 12-month $55 puts (or equivalent protective collars) to cap downside to ~10% while preserving arb upside to $61.25.
• If already long TXNM, sell Jan/Feb 2026 $62.50 covered calls to harvest premium and raise yield; close or roll if stock trades >$61 or if SEC/PUC filings indicate approval is imminent.
• Implement a pair trade: go long TXNM arb (≤$59) and short XLU notional-equal (size 0.5–1% AUM) to isolate deal-specific outcomes; unwind on formal regulator approval, a competing bid >$63, or if spread widens >$5 indicating deal stress.
• Monitor specific catalysts daily: NM PRC docket entries and TX PUCT filings for TXNM within the next 30–90 days; if regulators set approval timelines beyond Q4 2026 or issue adverse conditions, reduce TXNM exposure by 50% within 48 hours.